Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
about
Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer.GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells.Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon CancerAMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin.The untapped potential of tyrosine-based G protein signaling.Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time.Molecular mechanism of Gαi activation by non-GPCR proteins with a Gα-Binding and Activating motif.Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin.GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein.Fluorescence polarization assays to measure interactions between Gα subunits of heterotrimeric G proteins and regulatory motifs.A biochemical and genetic discovery pipeline identifies PLCδ4b as a nonreceptor activator of heterotrimeric G-proteins
P2860
Q36621729-2B8CD5C9-84EC-46C5-BC23-C70A5DDF96CDQ36778873-91AE38BA-63F3-46CE-AA38-BD2445D13007Q37100057-1C0B5F20-4AFE-4CA4-9C16-DE638EFD2E27Q37429741-7EA7CF85-FC09-422B-AFF8-BA5952D309C0Q38710732-05750FF8-297E-417A-BB34-B0744BB4E778Q38734798-E7790C7F-D6C7-4604-9F4E-7C4F7252EB57Q42150320-C534AF43-009C-4CD5-BC32-CB297D4C0159Q42705481-51E58A2A-8F17-451F-8563-AD0229C2773AQ45909882-DEB2FDEE-D0A2-434B-8FCF-9F4B0783A0E8Q47278890-20954DB9-8A7B-4719-BA42-E4F2985DBFA3Q47407152-5AC744F6-BB8A-4421-B2E6-50E0B989F24CQ47721663-65C30391-276F-4F50-9919-D8635FCA1737Q58757963-77E0FBF6-0068-4567-900C-A0E8FB2E353F
P2860
Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@ast
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@en
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@nl
type
label
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@ast
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@en
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@nl
prefLabel
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@ast
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@en
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@nl
P2860
P921
P356
P1433
P1476
Heterotrimeric G proteins as e ...... aign striking heads of a Hydra
@en
P2093
Pradipta Ghosh
P2860
P304
P356
10.18632/AGING.100781
P407
P5008
P577
2015-07-01T00:00:00Z